Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

Christopher Patterson, John W. Feightner, Angeles Garcia, G.-Y. Robin Hsiung, Christopher MacKnight and A. Dessa Sadovnick
CMAJ February 26, 2008 178 (5) 548-556; DOI: https://doi.org/10.1503/cmaj.070796
Christopher Patterson MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John W. Feightner MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angeles Garcia MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.-Y. Robin Hsiung MD MHSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher MacKnight MD MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Dessa Sadovnick PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading
  • © 2008 Canadian Medical Association

Abstract

Background: In addition to nonmodifiable genetic risk factors, potentially modifiable factors such as hypertension, hyperlipidemia and environmental exposures have been identified as risk factors for Alzheimer disease. In this article, we provide physicians with practical guidance on risk assessment and primary prevention of Alzheimer disease based on recommendations from the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, held in March 2006.

Methods: We developed evidence-based guidelines using systematic literature searches, with specific criteria for study selection and quality assessment, and a clear and transparent decision-making process. We selected studies published from January 1996 to December 2005 that met the following criteria: dementia (all-cause, Alzheimer disease or vascular dementia) as the outcome; longitudinal cohort study; study population broadly reflective of Canadian demographics; and genetic risk factors and general risk factors (e.g., hypertension, education, occupation and chemical exposure) identified. We graded the strength of evidence using the criteria of the Canadian Task Force on Preventive Health Care.

Results: Of 3424 articles on potentially modifiable risk factors for dementia, 1719 met our inclusion criteria; 60 were deemed to be of good or fair quality. Of 1721 articles on genetic risk factors, 62 that met our inclusion criteria were deemed to be of good or fair quality. On the basis of evidence from these articles, we made recommendations for the risk assessment and primary prevention of Alzheimer disease. For the primary prevention of Alzheimer's disease, there is good evidence for controlling vascular risk factors, especially hypertension (grade A), and weak or insufficient evidence for manipulation of lifestyle factors and prescribing of medications (grade C). There is good evidence to avoid estrogens and high-dose (> 400 IU/d) of vitamin E for this purpose (grade E). Genetic counselling and testing may be offered to at-risk individuals with an apparent autosomal dominant inheritance (grade B). Screening for the apolipoprotein E genotype in asymptomatic individuals in the general population is not recommended (grade E).

Interpretation: Despite the personal and societal burden of dementia, our understanding of genetic predisposition to dementias and the contribution of other risk factors remains limited. More importantly, there are few data to explain the overall risks and benefits of prevention strategies or their impact of risk modification.

View Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 178 (5)
CMAJ
Vol. 178, Issue 5
26 Feb 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Christopher Patterson, John W. Feightner, Angeles Garcia, G.-Y. Robin Hsiung, Christopher MacKnight, A. Dessa Sadovnick
CMAJ Feb 2008, 178 (5) 548-556; DOI: 10.1503/cmaj.070796

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease
Christopher Patterson, John W. Feightner, Angeles Garcia, G.-Y. Robin Hsiung, Christopher MacKnight, A. Dessa Sadovnick
CMAJ Feb 2008, 178 (5) 548-556; DOI: 10.1503/cmaj.070796
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • The case
    • Approach to risk assessment
    • Risk estimation
    • Prevention of Alzheimer disease
    • Knowledge gaps
    • The case revisited
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • PubMed
  • Google Scholar

Cited By...

  • Community social support and onset of dementia in older Japanese individuals: a multilevel analysis using the JAGES cohort data
  • Brain geometry matters in Alzheimers disease progression: a simulation study
  • Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial
  • Care of community-dwelling older adults with dementia and their caregivers
  • Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia: Recommendations for family physicians
  • Quatrieme conference consensuelle sur le diagnostic et le traitement de la demence: Recommandations pour les medecins de famille
  • Interprofessional and integrated care of the elderly in a family health team
  • How applicable are clinical practice guidelines to elderly patients with comorbidities?
  • Hypoxia and Alzheimer disease
  • Hypoxia and Alzheimer disease
  • Diagnosis and treatment of dementia: 2. Diagnosis
  • Google Scholar

More in this TOC Section

  • Parechovirus infections in infants
  • Radiation dermatitis in a patient treated for hepatocarcinoma
  • Spontaneous bacterial peritonitis in cirrhosis
Show more Practice

Similar Articles

Collections

  • Topics
    • Dementia & Alzheimer disease
    • Genetics
    • Geriatric medicine

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire